News & Events

adMare BioInnovations & Accel-Rx Unite to Advance the Canadian Life Sciences Sector

The addition of Accel-Rx’s expertise in seed stage investments and entrepreneur development strengthens adMare’s position as a single-stop destination with the...

Read the article

adMare BioInnovations Appoints Dr. Mounia Azzi as Vice President, Program Development and Partnerships

With deep experience in corporate and business development, Dr. Azzi will work closely with adMare’s Venture Partners to build their portfolios...

Read the article

adMare Academy Announces New Executive Institute Cohort to Drive the Canadian Life Sciences Industry Forward

With applications more than doubling for year two, the program Adjudication Committee has selected 19 executives, 10 women and 9 men,...

Read the article

Life Sciences & Health Technology Innovation Hub Takes Shape in Montreal

The NEOMED Innovation Centre will be expanded with the construction of a new innovation and commercialization complex specializing in life sciences...

Read the article

adMare BioInnovations Appoints Dr. Youssef Bennani as Venture Partner

With more than 25 years of experience in pharmaceutical R&D leadership and management, serving most recently as Site Head and VP...

Read the article

CDRD & NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovations

With its combined strength, adMare will prioritize high-value job creation through an impactful and sustainable Canadian life sciences industry; which will...

Read the article

Hope on the horizon for hard-to-treat breast cancers

NEOMED, CQDM, the Canadian Cancer Society, the Goodman Cancer Research Centre & the Lady Davis Institute announced a unique multi-party collaboration...

Read the article

CDRD & TRIUMF Announce Collaboration to Revolutionize the Fight Against Cancer with Targeted Alpha Therapy

By combining TRIUMF’s expertise in manufacturing isotopes and radiolabelling conjugates with CDRD’s ability to identify and validate potential biological targets to...

Read the article

The Renaissance of Radio Pharmaceuticals – A Commercial Perspective

CDRD is a proud sponsor of the TAT11 International Symposium on targeted alpha therapy hosted by Canadian Nuclear Laboratories. We are...

Read the article

New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration

NEOMED, GSK, CHUM Research Centre & University College London announced that they have entered into a strategic collaboration to explore the...

Read the article